Literature DB >> 8053897

Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate.

E Diez1, F H Chilton, G Stroup, R J Mayer, J D Winkler, A N Fonteh.   

Abstract

Previous studies using phospholipid mixed vesicles have demonstrated that several types of phospholipase A2 (PLA2) enzymes exhibit different selectivity for fatty acids at the sn-2 position, for the type of chemical bond at the sn-1 position or for the phosphobase moiety at the sn-3 position of phospholipids. In the present study, we have utilized natural mammalian membranes from U937 monocytes to determine whether two purified 14 kDa PLA2 isoenzymes (Type I, Type II) and a partially purified 110 kDa PLA2 exhibit substrate selectivity for certain fatty acids or phospholipids. In these studies, arachidonic acid (AA) release from membranes was measured under conditions where the remodelling of AA mediated by CoA-independent transacylase (CoA-IT) activity has been eliminated. In agreement with the mixed-vesicle models, AA was the major unsaturated fatty acid hydrolysed from membranes by the 110 kDa PLA2, suggesting that this PLA2 is selective in releasing AA from natural membranes. By contrast, Type I and Type II PLA2s were less selective in releasing AA from phospholipids and released a variety of unsaturated fatty acids at molar ratios that were proportional to the ratios of these fatty acids in U937 microsomal membranes. Examination of AA release from phospholipid classes indicated that all three enzymes released AA from the major AA-containing phospholipid classes (phosphatidylethanolamine, phosphatidylcholine, and phosphatidylinositol) of U937 membranes. The 110 kDa PLA2 released AA from phospholipid subclasses in ratios that were proportional to the AA content within phospholipid classes and subclasses of U937 membranes. These data suggested that the 110 kDa PLA2 shows no preference either for the sn-1 linkage or for the sn-3 phosphobase moiety of phospholipids. By contrast, Type I and Type II PLA2s preferentially released AA from ethanolamine-containing phospholipids and appeared to prefer the 1-acyl-linked subclass. Taken together, these data indicate that the 110 kDa PLA2 selectively releases AA from U937 membranes, whereas Type I and Type II PLA2 release a variety of unsaturated fatty acids. Furthermore, the 110 kDa PLA2 releases the same molar ratios of AA from all major phospholipid subclasses, whereas Type I and Type II PLA2s show some specificity for phosphatidylethanolamine when these enzymes are incubated with a complex mammalian membrane substrate.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8053897      PMCID: PMC1137047          DOI: 10.1042/bj3010721

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

Review 2.  Prostaglandins and leukotrienes as inflammatory mediators.

Authors:  J A Salmon; G A Higgs
Journal:  Br Med Bull       Date:  1987-04       Impact factor: 4.291

3.  Structure of bovine pancreatic phospholipase A2 at 1.7A resolution.

Authors:  B W Dijkstra; K H Kalk; W G Hol; J Drenth
Journal:  J Mol Biol       Date:  1981-03-25       Impact factor: 5.469

4.  Stimulated production and natural occurrence of 1,2-diarachidonoylglycerophosphocholine in human neutrophils.

Authors:  F H Chilton; R C Murphy
Journal:  Biochem Biophys Res Commun       Date:  1987-06-30       Impact factor: 3.575

5.  Arachidonoyl transacylase in human platelets. Coenzyme A-independent transfer of arachidonate from phosphatidylcholine to lysoplasmenylethanolamine.

Authors:  R M Kramer; D Deykin
Journal:  J Biol Chem       Date:  1983-11-25       Impact factor: 5.157

6.  Transacylation of lyso platelet-activating factor and other lysophospholipids by macrophage microsomes. Distinct donor and acceptor selectivities.

Authors:  T Sugiura; Y Masuzawa; Y Nakagawa; K Waku
Journal:  J Biol Chem       Date:  1987-01-25       Impact factor: 5.157

7.  Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid.

Authors:  J J Seilhamer; W Pruzanski; P Vadas; S Plant; J A Miller; J Kloss; L K Johnson
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

8.  Identification of neutral active phospholipase C which hydrolyzes choline glycerophospholipids and plasmalogen selective phospholipase A2 in canine myocardium.

Authors:  R A Wolf; R W Gross
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

9.  Changes in the composition of fatty chains of diacyl, alkylacyl and alkenylacyl ethanolamine and choline phosphoglycerides during the development of chick heart ventricular cells. High accumulation of 22-carbon fatty acid in ether phospholipids.

Authors:  Y Nakagawa; K Waku; Y Ishima
Journal:  Biochim Biophys Acta       Date:  1982-09-14

10.  Characterization of extracellular phospholipase A2 in rheumatoid synovial fluid.

Authors:  P Vadas; E Stefanski; W Pruzanski
Journal:  Life Sci       Date:  1985-02-11       Impact factor: 5.037

View more
  22 in total

1.  A2B5+/GFAP+ Cells of Rat Spinal Cord Share a Similar Lipid Profile with Progenitor Cells: A Comparative Lipidomic Study.

Authors:  Yutaka Itokazu; Nobuyoshi Tajima; Laura Kerosuo; Pentti Somerharju; Hannu Sariola; Robert K Yu; Reijo Käkelä
Journal:  Neurochem Res       Date:  2016-02-25       Impact factor: 3.996

2.  Pasteurella haemolytica leukotoxin-induced increase in phospholipase A2 activity in bovine neutrophils.

Authors:  Z Wang; C Clarke; K Clinkenbeard
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Metabolism and phospholipid assembly of polyunsaturated fatty acids in human bone marrow mesenchymal stromal cells.

Authors:  Feven Tigistu-Sahle; Milla Lampinen; Lotta Kilpinen; Minna Holopainen; Petri Lehenkari; Saara Laitinen; Reijo Käkelä
Journal:  J Lipid Res       Date:  2016-11-16       Impact factor: 5.922

Review 4.  Platelet-activating factor: the biosynthetic and catabolic enzymes.

Authors:  F Snyder
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

5.  Studies on the cytosolic phospholipase A2 in immortalized astrocytes (DITNC) revealed new properties of the calcium ionophore, A23187.

Authors:  D Xue; J Xu; S O McGuire; D Devitre; G Y Sun
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

6.  Aging bone marrow mesenchymal stromal cells have altered membrane glycerophospholipid composition and functionality.

Authors:  Lotta Kilpinen; Feven Tigistu-Sahle; Sofia Oja; Dario Greco; Amarjit Parmar; Päivi Saavalainen; Janne Nikkilä; Matti Korhonen; Petri Lehenkari; Reijo Käkelä; Saara Laitinen
Journal:  J Lipid Res       Date:  2012-12-27       Impact factor: 5.922

7.  Substrate efflux propensity plays a key role in the specificity of secretory A-type phospholipases.

Authors:  Perttu Haimi; Martin Hermansson; Krishna Chaithanya Batchu; Jorma A Virtanen; Pentti Somerharju
Journal:  J Biol Chem       Date:  2009-11-02       Impact factor: 5.157

8.  Increased expression of human type IIa secretory phospholipase A2 antigen in arthritic synovium.

Authors:  O S Jamal; P G Conaghan; A M Cunningham; P M Brooks; V F Munro; K F Scott
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

9.  Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation.

Authors:  E Ribaldi; A M Mezzasoma; E Francescangeli; M Prosdocimi; G G Nenci; G Goracci; P Gresele
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

Review 10.  Intracellular- and extracellular-derived Ca(2+) influence phospholipase A(2)-mediated fatty acid release from brain phospholipids.

Authors:  Angelo O Rosa; Stanley I Rapoport
Journal:  Biochim Biophys Acta       Date:  2009-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.